|
| Home : Prospect Park Capital Receives First Returns From Its Initial Investment |
|
Nov 17
2015 |
Prospect Park Capital Receives First Returns From Its Initial Investment |
|
TORONTO, ONTARIO--(Marketwired - Nov. 16, 2015) - Prospect Park Capital Corp. ("Prospect Park") (TSX VENTURE:PPK), a public healthcare focused investment corporation, announces that its initial investment in IOI, LLC ("IOI") has been purchased by a private investment group. Prospect Park invested in IOI as a limited partner thereby participating in IOI's subordinated note to finance Serenity Pharmaceuticals, LLC ("Serenity"). Serenity is a private pharmaceutical company dedicated to the development of pharmaceuticals in the urological area. In consideration for selling its membership interest in IOI, Prospect Park has received its initial capital returned (US$150,000) plus an 8% return (US$12,000) and the retained ability to collect an additional 32% should the Serenity drug successfully receive approval by the United States Food and Drug Administration. |
|
|
|
| Source:http://www.marketwired.com/mw/release.do?id=2074197&sourceType=3 |
| |
|
Related News
|
» AccuShares(R) Investment Management, LLC Announces Regular Distribution for the AccuShares Spot CBOE(R) VIX(R) Up Shares and Down Shares and, If Applicable, Net Income Distribution for the AccuShares Spot CBOE VIX Up Shares and Down Shares
» Tantalex Resources Corporation Provides Update
|
|
|
